TRIOLO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 13.732
EU - Europa 7.683
AS - Asia 5.840
SA - Sud America 897
AF - Africa 142
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 7
Totale 28.344
Nazione #
US - Stati Uniti d'America 13.555
SG - Singapore 2.083
IT - Italia 1.776
CN - Cina 1.704
RU - Federazione Russa 1.645
FI - Finlandia 926
DE - Germania 910
BR - Brasile 726
UA - Ucraina 638
HK - Hong Kong 608
VN - Vietnam 497
GB - Regno Unito 350
PL - Polonia 341
IE - Irlanda 312
FR - Francia 284
JP - Giappone 231
SE - Svezia 179
KR - Corea 145
IN - India 122
CA - Canada 89
BD - Bangladesh 79
NL - Olanda 64
AR - Argentina 60
RO - Romania 57
MX - Messico 52
TR - Turchia 51
IQ - Iraq 45
BE - Belgio 42
AU - Australia 37
ES - Italia 37
ZA - Sudafrica 29
UZ - Uzbekistan 28
EC - Ecuador 24
ID - Indonesia 24
CO - Colombia 21
IR - Iran 21
PK - Pakistan 21
AT - Austria 20
VE - Venezuela 19
CH - Svizzera 18
EG - Egitto 17
PY - Paraguay 17
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
CI - Costa d'Avorio 15
GR - Grecia 15
JO - Giordania 15
LT - Lituania 15
PH - Filippine 15
CL - Cile 14
KE - Kenya 14
LB - Libano 14
MA - Marocco 14
NP - Nepal 14
CZ - Repubblica Ceca 13
DZ - Algeria 13
MY - Malesia 12
TN - Tunisia 11
AZ - Azerbaigian 10
CR - Costa Rica 10
IL - Israele 10
TH - Thailandia 9
TW - Taiwan 9
BO - Bolivia 8
DK - Danimarca 8
GE - Georgia 8
BG - Bulgaria 6
EU - Europa 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
OM - Oman 6
SN - Senegal 6
ET - Etiopia 5
KG - Kirghizistan 5
PA - Panama 5
AL - Albania 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
UY - Uruguay 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
GA - Gabon 3
MD - Moldavia 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AM - Armenia 2
HN - Honduras 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
RS - Serbia 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 28.318
Città #
Ashburn 1.591
Fairfield 1.558
Singapore 1.456
Woodbridge 835
Seattle 704
Chandler 698
San Jose 645
Wilmington 645
Houston 604
Hong Kong 568
Ann Arbor 546
Cambridge 528
Secaucus 341
Jacksonville 334
Moscow 321
Dublin 310
Zgierz 307
Palermo 300
Des Moines 267
Medford 250
Beijing 248
Helsinki 232
Los Angeles 226
Tokyo 219
Santa Clara 210
Council Bluffs 208
Nanjing 194
Frankfurt am Main 190
Ho Chi Minh City 169
Princeton 158
Hefei 151
New York 151
Altamura 146
Dallas 139
Lauterbourg 138
Boardman 116
Chicago 111
The Dalles 109
Hanoi 107
Milan 105
Lawrence 103
San Diego 100
Tulsa 91
Dearborn 90
Jinan 89
Shenyang 74
Nanchang 73
Buffalo 69
São Paulo 60
Tianjin 55
Changsha 52
Rome 48
Ludwigshafen am Rhein 47
Seoul 47
Hebei 46
Jiaxing 43
London 40
Brussels 39
Seongnam 39
Zhengzhou 37
Guangzhou 35
Phoenix 35
Amsterdam 34
Columbus 32
Ningbo 31
Orem 31
Ottawa 28
Warsaw 28
Da Nang 27
Bologna 26
San Mateo 25
Verona 25
Rio de Janeiro 24
Toronto 24
Haiphong 22
Lanzhou 22
Boston 21
Hangzhou 21
Kumar 21
Saint Petersburg 21
Brooklyn 19
Johannesburg 19
Redwood City 19
Venice 19
Atlanta 18
City of London 18
Orange 18
Salt Lake City 18
Tashkent 18
Manchester 17
Munich 17
Taizhou 17
Turku 17
Belo Horizonte 16
Izmir 16
San Paolo di Civitate 16
Shanghai 16
Abidjan 15
Amman 15
Baghdad 15
Totale 18.253
Nome #
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 1.076
Malattia di KiKuchi-Fujimoto e lupus eritematoso sistemico: quale connessione ?. 513
Alterations of the beneficial effect of deep inspiration in scleroderma: relationships between lung function and imaging. 323
Ectopic expression of CXCL13, BAFF, APRIL and LT-ß is associated with artery tertiary lymphoid organs in giant cell arteritis 308
Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response 283
Cognitive impairment in Behcet’s disease patients without overt neurological involvement 282
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 282
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 280
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. 278
Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population 277
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity. 276
Associazione tra spondiloartrite e gammopatia monoclonale: tre casi clinici 259
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 255
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis 254
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 251
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 245
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease. 243
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 241
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. 238
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes 238
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 237
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 236
New insights into the pathogenesis of giant cell arteritis 236
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 233
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. 232
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 232
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 232
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome 228
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 226
Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. 226
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. 226
Atherosclerosis in female patients with rheumatoid arthritis: a two years of follow up 224
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 224
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis 220
IL-17 polarization of MAIT cells is derived from the activation of two different pathways 219
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis 218
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 218
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis 217
La determinazione degli anticorpi anti-peptide ciclico citrullinato è utile nel discriminare pazienti con artrite reumatoide da quelli con poliartrite associata a tiroidite cronica autoimmune 217
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 217
Arteriosclerosi ed artrite reumatoide: ruolo della terapia biologica 213
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 213
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 212
ANALISI DEI POLIMORFISMI DEL PEPTIDE SEGNALE DEL TGF-β1 IN GRUPPO DI PAZIENTI AFFETTI DA MALATTIA DI BEHÇET 209
Atherosclerosis in females patients with rheumatoid arthritis; a two years follow-up. 208
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response 207
Ruolo della terapia con aspirina e con immunoglobuline endovena nella poliabortività associata a sindrome da anticorpi anti-fosfolipidi 206
HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities 203
Atherosclerosis in female patients with rheumatoid arthritis; a two years follow-up 201
Epidemiology and risk factors in osteoarthritis: literature review data from "OASIS" study 198
Aterosclerosi e artrite reumatoide: ruolo della twerapia biologica 196
IVIG in APS pregnancy 196
Brief Report: Intestinal dysbiosis in ankylosing spondylitis 196
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 191
Disfunzione diastolica in pazienti affetti da artrite reumatoide: ruolo della terapia con anti-TNFα 190
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 190
Artropatia sclerodermica ed artrite reumatoide non evidenza di overlap 189
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. 189
Impatto del trattamento precoce con infliximab + methotrexate ed alte dosi di prednisone (PDN) vs infliximab (IFX) + methotrexate (MTX) e basse dosi di steroide nella very early rheumatoid arthritis (VERA): contributo casistico 187
Disfunzione diastolica in pazienti affetti da artrite reumatoide:ruolo della terapia con anti-TNF 187
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 186
AUTOPHAGY, BUT NOT THE UNFOLDED PROTEIN RESPONSE, REGULATES THE EXPRESSION OF IL-23 IN THEGUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND SUBCLINICAL GUT INFLAMMATION 185
Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome. 185
Artropatia sclerodermica ed artrite reumatoide: non evidenza di overlap 184
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 184
Pathogenesis of polymyalgia rheumatica 181
Subclinical gut inflammation in ankylosing spondylitis 179
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 179
Giant cell arteritis associated with chronic active Epstein-Barr virus infection. 178
Rapida induzione di remissione di un caso di malattia di Vogt-Koyonagi-Harada recidivante dopo terapia con infliximab 177
pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease 177
Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis 175
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 174
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 174
IBD e malattie reumatiche. Malattia di Crohn e spondilite anchilosante: una patogenesi comune? 173
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 173
Iniezione locale di infliximab nel trattamento della dattilite 171
Athersoclerosis in females patients with rheumatoid arthritis: a two years follow-up 171
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 171
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 170
Interleukin-9 and T helper type 9 cells in rheumatic diseases 170
Profilo citochinico ed espressione di STATS e SOCS nell’intestino di pazienti affetti da spondilite anchilosante 168
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 168
New approaches in the treatment of Adamantiades-Behcet's disease 167
THE LEVEL OF SOLUBLE GRANZYME A IS ELEVATED IN THE PLASMA AND IN THE Vgamma9/Vdelta2 T CELL CULTURE SUPERNATANTS OF PATIENTS WITH ACTIVE BEHCET'S DISEASE 166
Micofenolato mofetil nell’alveolite sclerodermica: uno studio pilota 166
Diastolic dysfunction in patients with rheumatoid arthritis treated with TNF blocking agents 165
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 165
Efficacia e sicurezza di infliximab nelle spondiloartriti indifferenziate: follow-up a 2 anni 163
The level of solubile granzyme A is elevated in the plasma and in the Vγ9/Vδ2 T cell culture supernatants of patients with active Behçet's disease. 163
Valutazione mediante hrct delle specifiche alterazioni polmonari nelle diverse forme cliniche di sclerosi sistemica 162
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 162
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. 162
Impatto del trattamento precoce con infliximab + methotrexate (MTX) ed alte dosi di prednisone (PDN) vs infliximab (IFX)+methotrexate (MTX) e basse dosi di steroide nella very early rheumatoid arthritis (VERA): contributo casistico 161
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 161
Lack of association of the -463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients. 160
La gestione farmacologica dei pazienti con malattie reumatologiche nell’insufficienza renale 160
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. 160
Efficacia e sicurezza del trattamento con inibitori del TNF in pazienti affetti da spondilite anchilosante: uno studio osservazionale a 2 anni. 158
Intestinal dysbiosis and innate immune responses in axial spondyloarthritis 157
Totale 21.712
Categoria #
all - tutte 91.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021449 0 0 0 0 0 0 0 0 0 0 202 247
2021/20221.840 91 424 58 70 57 74 87 112 183 246 113 325
2022/20232.373 248 397 29 216 298 344 223 174 246 33 118 47
2023/2024935 65 151 72 50 86 205 106 48 12 28 11 101
2024/20252.728 52 165 146 245 117 94 202 191 196 269 358 693
2025/202610.253 609 546 571 1.065 892 1.399 1.466 956 825 1.598 326 0
Totale 29.010